Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

By C. Bridges, A. Winquist, K. Fukuda, N. Cox, J. Singleton, R. Strikas. MMWR Recommendations and Reports, 2000

3,373 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Clinical relevance of age-related immune dysfunction. (2000, background): “The Centers for Disease Control and Prevention's report on prevention and control of influenza states that when the antigenic match between vaccine and circulating virus is close, infection is prevented in 70%-90% of subjects aged <65 years, compared with only 30%-40% of those aged >65 years [6].”
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, unknown): “creased risk for complications from influenza [133].”
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Prevention and control of influenza CDC 2005 (37)”
Mortality associated with influenza and respiratory syncytial virus in the United States. (2003, methodology): “INFLUENZA INFECTIONS RESULT IN substantial morbidity and mortality nearly every year(1,2) and estimates of this burden have played a pivotal role in formulating influenza vaccination policy in the United States.(3) However, numbers of deaths attributable to influenza are difficult to estimate direct”